Genmab — Juni 2018
-
Takeda also starts recruiting Ninlaro/Dara/Dex https://clinicaltrials.gov/ct2/history/NCT03439293?A=2&B=3&C=merged
-
also starts recruiting
https://clinicaltrials.gov/ct2/history/NCT03384654?A=6&B=7&C=merged -
A Phase II Study of Daratumumab plus Ibrutinib in Patients with Waldenstrom’s Macroglobulinemia https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-ii-study-of-daratumumab-plus-ibrutinib-in-patients-with-waldenstrom’s-macroglobulinemia
-
God morgen.

-
God morgen.

-
Nyt lille studie med Dara mod Acute Myeloid Leukemia https://clinicaltrials.gov/ct2/show/NCT03537599?term=03537599&rank=1
-
God morgen

-
God morgen. Hvis nogen har adgang til JP "TROEN PÅ GENMABS DARZALEX ER INTAKT
Et afbrudt studie, som investorer og selskab havde satset stort på, kostede i maj 20 pct. af Genmabs markedsværdi. Det virker overdrevet, selv om der er visse usikkerheder blandt andet om afhængigheden af et enkelt produkt. (Side 10-11) /ritzau/FINANS"
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind